http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012533603-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04 |
| filingDate | 2010-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2012533603-A |
| titleOfInvention | Condensed aminodihydro-oxazine derivatives |
| abstract | Ring A is a C 6-14 aryl group, L is —NR e CO—, etc. (where R e is a hydrogen atom, etc.), Ring B is a C 6-14 aryl group, etc. X is a C 1-3 alkylene group, Y is a single bond, Z is a C 1-3 alkylene group, R 1 and R 2 are each independently a hydrogen atom, R 3 , R 4 , R 5 and R 6 are independently a hydrogen atom, a halogen atom or the like, a compound represented by the general formula (I) or a pharmaceutically acceptable salt thereof or a solvate thereof, It has an inhibitory effect or BACE1 inhibitory effect and is useful as a prophylactic or therapeutic agent for neurodegenerative diseases caused by Aβ and typified by Alzheimer's dementia. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020503294-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019514987-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012533602-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7148518-B2 |
| priorityDate | 2009-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 525.